Top Momentum Stock to Consider Purchasing on March 4th
Top Momentum Stocks to Watch on March 4
If you're seeking stocks with strong upward trends and favorable buy ratings, consider these three companies making waves today:
BrightSpring Health Services, Inc. (BTSG)
BrightSpring Health Services, Inc. BTSG is a leading provider of integrated healthcare solutions, specializing in home and community-based pharmacy and care services for individuals with complex or chronic health needs. The company currently holds a Zacks Rank #1 (Strong Buy), and analyst consensus for its annual earnings has climbed by 10% in the past two months.
Over the last quarter, BrightSpring's stock price surged 15.7%, outperforming the S&P 500, which slipped by 0.7%. The company also boasts an impressive Momentum Score of A.
XP Inc. (XP)
XP XP operates a technology-driven financial services platform, primarily serving clients in Brazil with a broad range of investment products. The company is rated Zacks Rank #1, and its earnings outlook has improved by 4.7% over the last 60 days.
XP's shares have appreciated by 3.2% in the past three months, again outpacing the S&P 500's decline. The company also earns an A for momentum.
Catalyst Pharmaceuticals, Inc. (CPRX)
Catalyst Pharmaceuticals CPRX is a biopharmaceutical company focused on developing and marketing treatments for rare and challenging diseases. With a Zacks Rank #1, the consensus estimate for its current year earnings has increased by 2% over the last two months.
Shares of Catalyst Pharmaceuticals have risen 3.6% over the last quarter, while the broader market declined. The company also holds an A Momentum Score.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Michael Saylor Is 'Buying Bitcoin Right Now' As BTC Tops $73,000
Viking Q4 Earnings & Revenues Surpass Estimates, Improve Y/Y


Bitcoin Hyper Price Prediction: DeepSnitch Outperforms HYPER and Remittix With 180% Rally

